Parametric model of combination therapy for Non-Hodgkin Lymphoma.
The development and clinical testing of drug combinations for the treatment of Non-Hodgkin Lymphoma (NHL) and other cancers has recently shown great promise. However, determining the optimum combination and its associated dosages for maximum efficacy and minimum side effects is still a challenge. Th...
Sparad:
| Huvudupphov: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Public Library of Science (PLoS)
2012-01-01
|
| Serie: | PLoS ONE |
| Länkar: | http://europepmc.org/articles/PMC3522695?pdf=render |
| Taggar: |
Inga taggar, Lägg till första taggen!
|